Drug Type Small molecule drug |
Synonyms BCR 0002, BCR0002 |
Target |
Action inhibitors |
Mechanism POLQ inhibitors(DNA polymerase theta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Discovery | China | 01 Nov 2024 | |
Rectal Cancer | Discovery | China | 01 Nov 2024 |